ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0277

TMEM16A/CLCA1 Activation Drives Tubular Dilation and Crystal Clearance in Calcium Oxalate Nephropathy

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Holznecht, Nickolas J., University of California Santa Barbara, Santa Barbara, California, United States
  • Strubl, Sebastian, University of California Santa Barbara, Santa Barbara, California, United States
  • Torres, Jacob A., University of California Santa Barbara, Santa Barbara, California, United States
  • Shapiro, Maria, University of California Santa Barbara, Santa Barbara, California, United States
  • Cao, James Ting, University of California Santa Barbara, Santa Barbara, California, United States
  • Arroyo, Alejandra, University of California Santa Barbara, Santa Barbara, California, United States
  • Tonum, Kanlayanee, Mahidol University Faculty of Science, Bangkok, Thailand
  • Soodvilai, Sunhapas, Mahidol University Faculty of Science, Bangkok, Thailand
  • Weimbs, Thomas, University of California Santa Barbara, Santa Barbara, California, United States
Background

Tubular retention of calcium oxalate (CaOx) crystals drives nephrolithiasis. We tested whether TMEM16A (Ca-activated Cl channel) and its regulator CLCA1 mediate tubular dilation to promote crystal clearance and examined STAT3/STAT6 as transcriptional regulators, primary cilia as determinants of recovery, and urinary CLCA1 as a tubular biomarker.

Methods

C57BL/6J male mice received 0.67% sodium oxalate (NaOx) chow for 3–14 days with DMSO vehicle, TMEM16A inhibitor (10 mg/kg SID i.p.), Ksp:cre STAT3 KO, STAT6 KO, or primary cilia disruption (Ift88 cKO). Endpoints: histopathology, immunofluorescence, Western blot, qRT-PCR, patch-clamp, 24-hour urine output, serum creatinine, and urinary CLCA1 ELISA.

Results

NaOx feeding induced rapid CaOx crystal deposition renal tubules, with TMEM16A/CLCA1 upregulation and apical redistribution, tubular dilation, and increased urine output. TMEM16A inhibition abolished tubular dilation and crystal clearance, increased crystal retention, and caused mortality. STAT3 KO impaired proximal TMEM16A/CLCA1 induction and dilation; STAT6 KO impaired distal dilation without mortality. Ift88 cKO mice showed failure to return to tubular diameter post-crystal clearance; survivors developed persistent dilation and cystogenesis. Urinary CLCA1 correlated with crystal burden and tubular dilation.

Conclusion

TMEM16A/CLCA1 function is essential for CaOx-induced water secretion, tubular dilation, crystal clearance and urine output; absence is lethal. STAT3 and STAT6 govern segment-specific responses. Primary cilia are required for morphological recovery and cyst prevention. Urinary CLCA1 is a candidate biomarker of tubular secretory activation.

Funding

  • NIDDK Support